Huiting Li
Weifang Medical University
4 Papers
8 Citations
Huiting Li is an academic researcher from Weifang Medical University. The author has contributed to research in topics: Reperfusion injury & Chemistry. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
Protective role of N-acetyl-l-tryptophan against hepatic ischemia-reperfusion injury via the RIP2/caspase-1/IL-1β signaling pathway.
Jianxin Wang,Shuna Yu,Jianguo Li,Huiting Li,Hongxin Jiang,Peilun Xiao,Yitong Pan,Jie Zheng,Li Yu,Jiying Jiang +9 more
TL;DR: It is indicated that l- NAT may exert a hepatoprotective role in HIRI through inhibiting RIP2/caspase-1/IL-1β signaling pathway, which can provide evidence for l-NAT to be a potential effective drug against HIRi during clinical practice.
23
Inhibition of excessive mitophagy by N-acetyl-L-tryptophan confers hepatoprotection against Ischemia-Reperfusion injury in rats.
Huiting Li,Yitong Pan,Hongjuan Wu,Shuna Yu,Jianxin Wang,Jie Zheng,Can Wang,Jianguo Li,Jiying Jiang +8 more
TL;DR: It is demonstrated that excessive mitophagy involved in the process of HIRI and L-NAT may protect hepatocytes against ischemia-reperfusion injury (HIRI) by inhibiting activation ofMitophagy and improving the structure and function of mitochondria.
17
N-acetyl-L-tryptophan attenuates hepatic ischemia-reperfusion injury via regulating TLR4/NLRP3 signaling pathway in rats.
Yitong Pan,Shuna Yu,Jianxin Wang,Wanzhen Li,Huiting Li,Chen Bai,Yaxin Sheng,Ming Li,Chenchen Wang,Jiao Liu,Peitong Xie,Can Wang,Jiying Jiang,Jianguo Li +13 more
TL;DR: In this paper, the authors investigated the changes of TLR4/NLRP3 signal during hepatic ischemia-reperfusion injury (HIRI) and to verify whether Nacetyl-L-tryptophan (L-NAT) protected hepatocytes by regulating the activation of TLRs 4/NLPs 3 signal.
Protective role of N-acetyl-L-tryptophan against hepatic ischemia-reperfusion injury by the TLR4/NF-ΚB signaling pathway
Jianxin Wang,Shuna Yu,Huiting Li,Hongxin Jiang,Peilun Xiao,Yitong Pan,Zhe Wang,Jie Zheng,Li Yu,Jiying Jiang +9 more
- 10 Jan 2019
TL;DR: In this paper, the authors investigated whether Nacetyl-L-tryptophan (L-NAT) could protect hepatocytes against acute hepatic ischemia-reperfusion injury through the TLR4/NF-κB signaling pathway and its possible mechanisms.
1